Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Shares Outstanding (2019 - 2025)

Inventiva (IVEVF) posted Shares Outstanding (Entity) of $193.2 million for Q4 2025, up 223.25% on a QoQ basis from $59.8 million in Q4 2024, and up 223.25% year-over-year from $59.8 million in Q4 2024.

Analysis

Inventiva (IVEVF) Shares Outstanding (2019 - 2025) Analysis & Trends

Inventiva has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $193.2 million in Q4 2025.

  • On a quarterly basis, Shares Outstanding (Entity) rose 223.25% year-over-year to $193.2 million in Q4 2025; TTM through Dec 2025 was $193.2 million, a 223.25% increase from a year earlier, with the FY2025 full-year figure at $193.2 million, up 223.25% from the prior year.
  • Shares Outstanding (Entity) was $193.2 million for Q4 2025 at Inventiva, up from $59.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $193.2 million in Q4 2025, with the low at $40.9 million in Q4 2021.
  • Average Shares Outstanding (Entity) over 5 years is $77.6 million, with a median of $52.1 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 3.08% in 2022, then jumped 223.25% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $40.9 million in 2021, then advanced by 3.08% to $42.1 million in 2022, then climbed by 23.69% to $52.1 million in 2023, then climbed by 14.7% to $59.8 million in 2024, then surged by 223.25% to $193.2 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $193.2 million (Q4 2025), $59.8 million (Q4 2024), and $52.1 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn 2.41 Bn
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn 1.77 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn 1.94 Bn
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn 5.70 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 44.38 Bn 44.38 Bn - 210.89 Mn
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn 200.38 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 42.60 Mn
10 Inventiva 693.72 Mn 693.72 Mn - 186.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 186.80 Mn
Jun 30, 2025 59.78 Mn
Dec 31, 2024 59.78 Mn
Jun 30, 2024 45.35 Mn
Dec 31, 2023 45.35 Mn
Jun 30, 2023 41.45 Mn
Dec 31, 2022 41.45 Mn
Sep 22, 2022 39.17 Mn
Jun 30, 2022 39.17 Mn
Dec 31, 2021 39.17 Mn
Jun 30, 2021 33.87 Mn
Mar 31, 2021 33.87 Mn
Dec 31, 2020 33.87 Mn
Jun 30, 2020 23.52 Mn
Mar 31, 2020 23.52 Mn
Dec 31, 2019 23.52 Mn